Alzheimer's Disease and the Evolution of Diagnosis
An early animation from my time as Director of Animation at AS&K Visual Science. Combining live action with 3D animation to create an engaging three minutes piece, briefly outlining the the history of AD diagnosis, from its discovery to modern day.
The Mode of Action of AmBisome - liposomal amphotericin B
Originally developed in 2010 for Gilead to illustrate the specific mode of action of this broad spectrum antifungal product. AS&K Visual Science were asked to reinvent an existing product with fresh branding and a 'high science' feel. After much successful use, the client returned to AS&K in 2015 for re-rendering of the animation in high definition for further use at events and symposia. Please find below a selection of frames from the animation.
Credit to Zoubein Rana , Edd Stockton and Naz Dabbs for their work on this animation.
Please view the final AmBisome MOA animation below
The Mode of Action of Halaven (eribulin mesylate) Injection
A more recent MOA animation from my time as Director of Animation at AS&K Visual Science, The Mode of Action of Halaven (eribulin mesylate) Injection for Eisai - full credit to the AS&K teams for their extensive input into this piece.